Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

AKBA

Akebia Therapeutics, Inc.

CIK 0001517022 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$1.43
↑ 0.01 (0.70%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$383.61M
P/E Ratio
-18.70
EPS
-0.02
Dividend Yield
Not covered
52W Position
19%
Beta
1.14

Valuation multiples

Fwd P/E
28.74
PEG
0.00
P/B
14.01
P/S
1.65
EV/Revenue
1.16
ROE
-74.9%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 19%
$0.82$4.08

Latest Financials

2025-12-31 FY
Revenue
$236.20M
Net Income
-$5.34M
Total Assets
$376.56M
Free Cash Flow
$67.70M

Recent news